It is still possible that RIPK3 signaling in hepatocytes is below our threshold of detection leading to sublethal necroptosis signaling or that RIPK1 may target MLKL to drive responses during liver disease (Günther et al, 2016; Xu et al, 2019; Majdi et al, 2020). Here, RIPK3 is linked to liver disorder.